Press Release
First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
As announced, initial proof-of-concept (POC) results from distinct ongoing investigator-initiated trial (IIT) in Abu Dhabi show crofelemer reduced total parenteral support in a pediatric MVID patient with intestinal failure by up to 27%; per the IIT protocol, patient was taken off crofelemer after 12 weeks of treatment for a period of 30 days, but was restarted on daily crofelemer treatment after just 8 days, as patient's symptoms were worsening Additional POC IIT results expected throughout 2025 for MVID; results from company's MVID Phase 2 study expected with completion of treatment in H2 2026 Ground-breaking results in single-digit number of MVID patients could potentially lead to expedited approval in the EU through PRIME and to Breakthrough Therapy designation in the US Read More
Press Release
Medal of Honor Recipients & WWII Heroes Lead the 20th Annual National Memorial Day Parade Ahead of the 250th Birthday of America’s Military
Hosted by Anthony Anderson & Aisha Tyler, the Parade Features Hollywood Stars and Performances by Scotty Hasting, Restless Road and Musicians From the United States Military Read More
Press Release
The Most Wanted Custom Silver Partners With Western Vaca to Promote Its Newest Jewelry Collection
The partnership is an ideal fit for both the silversmith brand and Western Vaca, a Mexico-based influencer that perfectly aligns with the style and sentiment of The Most Wanted Custom Silver's artisan jewelry products. Read More
Press Release
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
New ISOLED-D™ line delivers premium, scalable deuterated reagents for OLED synthesis, supporting the industry from R&D through commercial production with CIL's global manufacturing and expertise. Read More
Press Release
ZetrOZ Systems' sam(R) Wearable Ultrasound Helps Osteoarthritis Patients Return to Regular Activities
The sam® sustained acoustic medicine device can help millions of people suffering from knee osteoarthritis to find relief, without invasive surgery or potentially addictive painkiller medications. Read More
Press Release
Montgomery County Public Schools Educational Foundation Awards the "Cesar Pie Cyber Defender Scholarship"
During its annual Evening of Excellence ceremony, the MCPSEF awarded nearly 200 scholarships and awards including CSIOS Corporation's Cesar Pie Cyber Defender Scholarship. Read More
Press Release
Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Trial marks key milestone in driving pipeline progress Phase 1 trial scheduled for completion mid-June 2025 Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback Read More
Press Release
Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis
Key Regulatory Milestone Provides Clear Development Roadmap to Registration for MOTYS Initiation of Phase 3 Program Remains on Schedule to Begin in Q3 2025 Read More
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Reiterates $75M Guidance, Expected Profitability in Q4 on Adjusted EBITDA Basis Due to Pending Sportstech, Wattbike Deals
Company Updates Investor Presentation to Reflect Strong Q1 Earnings, More than $20M in Pro Forma Revenue and 15% Increase in 2025 Pro Forma Revenue Guidance Read More
Press Release
Why Are DEA’s Prevoznik and Strait Lecturing the World on Drug Policy While Undermining U.S. Marijuana Law?
The appearance of Thomas Prevoznik and Matthew Strait as thought leaders in global drug policy is more than just tone-deaf-it's dangerous. It validates a failed regulatory approach that punishes innovation, undermines public health, and sidelines scientific progress for political convenience Read More
Press Release
